Article
In the ophthalmic market, there is a distinctive gap between industry leaders and followers.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Zeiss Medical Technology gains NMPA approval for ILM-Blue in China
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
OSRX expands medication sizes and adds direct-to-patient post-op kits
(EyePod) From idea to impact: Navigating ophthalmic innovation
Optimization of IOL selection and techniques enhances cataract surgery outcomes
Ophthalmology sees AI-powered impact on cataract and diabetic eye disease